INMB 8-K 2026-07-01

Inmune Bio, Inc. (INMB) 8-K dated 2026-07-01 — accession 0001213900-26-073983. This URL is the filing, not the INMB hub.

Inmune Bio, Inc. (INMB) is a biotechnology company listed on US.

Inmune Bio, Inc. filed a 8-K on 2026-07-01. Accession 0001213900-26-073983.

Cached items: 1.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.

Not investment advice. The INMB SEC hub lists recent forms. The stock page is the research view.